Cancer patient perspective in the arena of COVID‐19 pandemic

Abstract

Objective The coronavirus disease 2019 (COVID‐19) outbreak has been declared a global pandemic of unprecedented proportions. Italy is a country which has been heavily affected. Cancer patients are at a higher risk owing to their intrinsic fragility related to their underlying disease and oncologic treatment. Against this backdrop, we conducted a survey to investigate how patients perceived their condition, clinical management and availability of information during the pandemic. Methods Between 15 April and 1 May 2020 a survey was submitted to cancer patients at oncology departments in the Marche region. Questions regarding the perception of personal safety, continuity of cancer care, information quality and psychological distress. Results Seven hundred patients participated in the survey; 59% were female and 40% were aged between 46 and 65. The majority of the participants perceived compliance with appropriate safety standards by cancer care providers and 80% were reassured about their concerns during the medical interview. 40% were worried of being at a higher risk of infection and 71% felt they were at a greater risk because of chemotherapy. 55% felt that postponing cancer treatment could reduce its efficacy, however 76% declared they did not feel abandoned at the time of treatment postponement. Patients between 46 and 65 years declared a significant reduction in sleep ( p < 0.01) and in concentration ( p = 0.03). Conclusions The emergency care offered to cancer patients has been deemed satisfactory in terms of both safety standards and care management. However, the majority of participants perceived the mutual negative influence between their oncologic disease and the risk of infection highlighting the need for special measures to ensure safe continuity of care.

Decision Conflicts in Clinical Care during COVID-19: A Patient Perspective

“…The importance and impact of background variables regarding the psychological distress and uncertainty is highly variable, as summarized in a recent review [ 39 ]. Based on our findings with an independency from the regional COVID-19 impact that was also seen in other German [ 40 , 41 ] and Italian [ 26 , 42 ] investigations, we conclude that these differences might be more related to the underlying healthcare systems, sociocultural influences or general residence to healthcare crisis in different countries.…”

Rising incidence of late stage breast cancer after COVID-19 outbreak. Real-world data from the Italian COVID-DELAY study

“…When desperate times called for drastic measures, diagnostic procedures and screening programs were deprioritized, routine clinical practices (such as follow up visits and multidisciplinary tumor meetings) reoriented to virtual care to reduce risk exposure and ease the pressure on hospital facilities [6,18]. Cancer patients, as a highly vulnerable population to better manage at a safe distance [19,20], remotely experienced this sudden disaster response coping with the fear of being left orphan of specialist care [21,22]. Considering the downside of this forced historic transition to telemedicine, the post-pandemic oncological scenario will hardly look the same in the forthcoming years [23].…”

A year of pandemic for European particle radiotherapy: A survey on behalf of EPTN working group

“…The anxiety and fears of oncological patients that had been judged to be at high death risk from Covid-19 had, therefore, a dramatic effect also on the start of treatment that was often autonomously postponed by the patients even with the reassurance of the oncological staff [20] , [21] , [22] . This might represent a serious collateral effect of Covid-19, considering the prolongation of the pandemic and require urgent intervention in order to promote mental oncological well-being ventures also through virtual communities.…”